Translating the science of patient-reported outcomes assessment into clinical practice.

Patient-reported outcomes (PROs) are based on direct reporting by patients without the intervention of an observer. They include the self-assessment of functional status, symptoms, and other concerns such as needs and satisfaction with care. Health-related quality of life (HRQOL) assessment is a form of PRO and often includes both functional status and symptoms. The science underlying the assessment of HRQOL in clinical practice requires an understanding of the relationships between symptoms, functional status, and HRQOL, as well as instrument selection, and analysis and interpretation of the data. A modification of the Wilson and Cleary model is proposed to show the likelihood of bidirectional relationships between symptoms, functions, and HRQOL. Instrument selection should be based on the measurement properties of the instruments and patient populations in which they will be used. Analyses of data that allow a calculation of the proportion of patients who benefit from an intervention are preferred to analyses that show only the mean change in scores from baseline. HRQOL assessment in clinical practice has been shown to lead to a better understanding of patients' concerns with improvement in counseling and referral for required services. Potentially, HRQOL assessment should also be used to monitor the progress of a patient's disease and benefit from treatment.

[1]  G. Norman,et al.  Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.

[2]  G. Guyatt,et al.  Economic analysis of respiratory rehabilitation. , 1997, Chest.

[3]  D. Osoba Self-rating symptom checklists: a simple method for recording and evaluating symptom control in oncology. , 1993, Cancer treatment reviews.

[4]  C. Lindley,et al.  Incidence and duration of chemotherapy-induced nausea and vomiting in the outpatient oncology population. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  D. Hand,et al.  Causal indicators in quality of life research , 1997, Quality of Life Research.

[6]  W. Tierney,et al.  Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. , 1999, Journal of clinical epidemiology.

[7]  Galina Velikova,et al.  Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  D. Osoba,et al.  Effect of postchemotherapy nausea and vomiting on health-related quality of life , 1997, Supportive Care in Cancer.

[9]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[10]  I. Wilson,et al.  Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. , 1995, JAMA.

[11]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  D. Osoba,et al.  The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires , 1996, Quality of Life Research.

[13]  D. Osoba,et al.  Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group. , 2005, European journal of cancer.

[14]  P. Selby,et al.  Computer-based quality of life questionnaires may contribute to doctor–patient interactions in oncology , 2002, British Journal of Cancer.

[15]  K. Sousa,et al.  Putting Wilson and Cleary to the Test: Analysis of a HRQOL Conceptual Model using Structural Equation Modeling , 2006, Quality of Life Research.

[16]  D. Osoba,et al.  Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Wilbur,et al.  Conceptual model of health-related quality of life. , 2005, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.

[19]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[20]  D. Osoba,et al.  Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  N. Aaronson,et al.  Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. , 2002, JAMA.

[22]  Gordon H Guyatt,et al.  Methods to explain the clinical significance of health status measures. , 2002, Mayo Clinic proceedings.

[23]  D. Osoba,et al.  Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life. , 1998, Quality of Life Research.

[24]  D. Osoba,et al.  Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer , 1994, Quality of Life Research.

[25]  G. Guyatt,et al.  Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.

[26]  C. Cleeland,et al.  Assessing symptom distress in cancer patients , 2000 .

[27]  D. Hand,et al.  Factor analysis, causal indicators and quality of life , 1997, Quality of Life Research.

[28]  D. Osoba,et al.  Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Mellar P. Davis,et al.  Cancer symptom assessment instruments: a systematic review. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.